ImaginAb Secures $5,341,245 New Funding Round

  • Feed Type
  • Date
    4/14/2016
  • Company Name
    ImaginAb
  • Mailing Address
    419 Hindry Avenue Inglewood, CA 90301 USA
  • Company Description
    ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
  • Website
    http://www.imaginab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,341,245
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed